Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancer

Background Bulk transcriptional profiles of early colorectal cancer (CRC) can fail to detect biological processes associated with disease-free survival (DFS) if the transcriptional patterns are subtle and/or obscured by other processes’ patterns. Consensus-independent component analysis (c-ICA) can...

Full description

Saved in:
Bibliographic Details
Published inCommunications medicine Vol. 4; no. 1; p. 79
Main Authors Knapen, Daan G., Hone Lopez, Sara, de Groot, Derk Jan A., de Haan, Jacco-Juri, de Vries, Elisabeth G. E., Dienstmann, Rodrigo, de Jong, Steven, Bhattacharya, Arkajyoti, Fehrmann, Rudolf S. N.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 03.05.2024
Springer Nature B.V
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Bulk transcriptional profiles of early colorectal cancer (CRC) can fail to detect biological processes associated with disease-free survival (DFS) if the transcriptional patterns are subtle and/or obscured by other processes’ patterns. Consensus-independent component analysis (c-ICA) can dissect such transcriptomes into statistically independent transcriptional components (TCs), capturing both pronounced and subtle biological processes. Methods In this study we (1) integrated transcriptomes ( n  = 4228) from multiple early CRC studies, (2) performed c-ICA to define the TC landscape within this integrated data set, 3) determined the biological processes captured by these TCs, (4) performed Cox regression to identify DFS-associated TCs, (5) performed random survival forest (RSF) analyses with activity of DFS-associated TCs as classifiers to identify subgroups of patients, and 6) performed a sensitivity analysis to determine the robustness of our results Results We identify 191 TCs, 43 of which are associated with DFS, revealing transcriptional diversity among DFS-associated biological processes. A prominent example is the epithelial-mesenchymal transition (EMT), for which we identify an association with nine independent DFS-associated TCs, each with coordinated upregulation or downregulation of various sets of genes. Conclusions This finding indicates that early CRC may have nine distinct routes to achieve EMT, each requiring a specific peri-operative treatment strategy. Finally, we stratify patients into DFS patient subgroups with distinct transcriptional patterns associated with stage 2 and stage 3 CRC. Plain language summary While treatments for patients with colorectal cancer have improved, many patients (around 30-50%) have cancers that will eventually relapse and these patients will die due to their disease. Researchers have been studying the genes involved in colorectal cancer to help us understand why some cancers might relapse. However, current methods to do this may miss subtle or hidden patterns in the gene activity related to cancer relapse. To deal with this, we used a special method called consensus-independent component analysis (c-ICA) to dig more deeply into the activity of genes. This helped us to uncover some potential biological processes underpinning colorectal cancer relapse, which ultimately could help researchers to identify better treatments for patients with colorectal cancer. Knapen et al. apply consensus-independent transcriptional component analysis to dissect transcriptomes into statistically independent transcriptional components in early colorectal cancer. Their findings identify 43 biological processes associated with disease-free survival which enables stratification of patients into different subgroups.
AbstractList BackgroundBulk transcriptional profiles of early colorectal cancer (CRC) can fail to detect biological processes associated with disease-free survival (DFS) if the transcriptional patterns are subtle and/or obscured by other processes’ patterns. Consensus-independent component analysis (c-ICA) can dissect such transcriptomes into statistically independent transcriptional components (TCs), capturing both pronounced and subtle biological processes.MethodsIn this study we (1) integrated transcriptomes (n = 4228) from multiple early CRC studies, (2) performed c-ICA to define the TC landscape within this integrated data set, 3) determined the biological processes captured by these TCs, (4) performed Cox regression to identify DFS-associated TCs, (5) performed random survival forest (RSF) analyses with activity of DFS-associated TCs as classifiers to identify subgroups of patients, and 6) performed a sensitivity analysis to determine the robustness of our resultsResultsWe identify 191 TCs, 43 of which are associated with DFS, revealing transcriptional diversity among DFS-associated biological processes. A prominent example is the epithelial-mesenchymal transition (EMT), for which we identify an association with nine independent DFS-associated TCs, each with coordinated upregulation or downregulation of various sets of genes.ConclusionsThis finding indicates that early CRC may have nine distinct routes to achieve EMT, each requiring a specific peri-operative treatment strategy. Finally, we stratify patients into DFS patient subgroups with distinct transcriptional patterns associated with stage 2 and stage 3 CRC.Plain language summaryWhile treatments for patients with colorectal cancer have improved, many patients (around 30-50%) have cancers that will eventually relapse and these patients will die due to their disease. Researchers have been studying the genes involved in colorectal cancer to help us understand why some cancers might relapse. However, current methods to do this may miss subtle or hidden patterns in the gene activity related to cancer relapse. To deal with this, we used a special method called consensus-independent component analysis (c-ICA) to dig more deeply into the activity of genes. This helped us to uncover some potential biological processes underpinning colorectal cancer relapse, which ultimately could help researchers to identify better treatments for patients with colorectal cancer.
Background Bulk transcriptional profiles of early colorectal cancer (CRC) can fail to detect biological processes associated with disease-free survival (DFS) if the transcriptional patterns are subtle and/or obscured by other processes’ patterns. Consensus-independent component analysis (c-ICA) can dissect such transcriptomes into statistically independent transcriptional components (TCs), capturing both pronounced and subtle biological processes. Methods In this study we (1) integrated transcriptomes ( n  = 4228) from multiple early CRC studies, (2) performed c-ICA to define the TC landscape within this integrated data set, 3) determined the biological processes captured by these TCs, (4) performed Cox regression to identify DFS-associated TCs, (5) performed random survival forest (RSF) analyses with activity of DFS-associated TCs as classifiers to identify subgroups of patients, and 6) performed a sensitivity analysis to determine the robustness of our results Results We identify 191 TCs, 43 of which are associated with DFS, revealing transcriptional diversity among DFS-associated biological processes. A prominent example is the epithelial-mesenchymal transition (EMT), for which we identify an association with nine independent DFS-associated TCs, each with coordinated upregulation or downregulation of various sets of genes. Conclusions This finding indicates that early CRC may have nine distinct routes to achieve EMT, each requiring a specific peri-operative treatment strategy. Finally, we stratify patients into DFS patient subgroups with distinct transcriptional patterns associated with stage 2 and stage 3 CRC. Plain language summary While treatments for patients with colorectal cancer have improved, many patients (around 30-50%) have cancers that will eventually relapse and these patients will die due to their disease. Researchers have been studying the genes involved in colorectal cancer to help us understand why some cancers might relapse. However, current methods to do this may miss subtle or hidden patterns in the gene activity related to cancer relapse. To deal with this, we used a special method called consensus-independent component analysis (c-ICA) to dig more deeply into the activity of genes. This helped us to uncover some potential biological processes underpinning colorectal cancer relapse, which ultimately could help researchers to identify better treatments for patients with colorectal cancer. Knapen et al. apply consensus-independent transcriptional component analysis to dissect transcriptomes into statistically independent transcriptional components in early colorectal cancer. Their findings identify 43 biological processes associated with disease-free survival which enables stratification of patients into different subgroups.
Bulk transcriptional profiles of early colorectal cancer (CRC) can fail to detect biological processes associated with disease-free survival (DFS) if the transcriptional patterns are subtle and/or obscured by other processes' patterns. Consensus-independent component analysis (c-ICA) can dissect such transcriptomes into statistically independent transcriptional components (TCs), capturing both pronounced and subtle biological processes. In this study we (1) integrated transcriptomes (n = 4228) from multiple early CRC studies, (2) performed c-ICA to define the TC landscape within this integrated data set, 3) determined the biological processes captured by these TCs, (4) performed Cox regression to identify DFS-associated TCs, (5) performed random survival forest (RSF) analyses with activity of DFS-associated TCs as classifiers to identify subgroups of patients, and 6) performed a sensitivity analysis to determine the robustness of our results RESULTS: We identify 191 TCs, 43 of which are associated with DFS, revealing transcriptional diversity among DFS-associated biological processes. A prominent example is the epithelial-mesenchymal transition (EMT), for which we identify an association with nine independent DFS-associated TCs, each with coordinated upregulation or downregulation of various sets of genes. This finding indicates that early CRC may have nine distinct routes to achieve EMT, each requiring a specific peri-operative treatment strategy. Finally, we stratify patients into DFS patient subgroups with distinct transcriptional patterns associated with stage 2 and stage 3 CRC.
BACKGROUNDBulk transcriptional profiles of early colorectal cancer (CRC) can fail to detect biological processes associated with disease-free survival (DFS) if the transcriptional patterns are subtle and/or obscured by other processes' patterns. Consensus-independent component analysis (c-ICA) can dissect such transcriptomes into statistically independent transcriptional components (TCs), capturing both pronounced and subtle biological processes.METHODSIn this study we (1) integrated transcriptomes (n = 4228) from multiple early CRC studies, (2) performed c-ICA to define the TC landscape within this integrated data set, 3) determined the biological processes captured by these TCs, (4) performed Cox regression to identify DFS-associated TCs, (5) performed random survival forest (RSF) analyses with activity of DFS-associated TCs as classifiers to identify subgroups of patients, and 6) performed a sensitivity analysis to determine the robustness of our results RESULTS: We identify 191 TCs, 43 of which are associated with DFS, revealing transcriptional diversity among DFS-associated biological processes. A prominent example is the epithelial-mesenchymal transition (EMT), for which we identify an association with nine independent DFS-associated TCs, each with coordinated upregulation or downregulation of various sets of genes.CONCLUSIONSThis finding indicates that early CRC may have nine distinct routes to achieve EMT, each requiring a specific peri-operative treatment strategy. Finally, we stratify patients into DFS patient subgroups with distinct transcriptional patterns associated with stage 2 and stage 3 CRC.
Abstract Background Bulk transcriptional profiles of early colorectal cancer (CRC) can fail to detect biological processes associated with disease-free survival (DFS) if the transcriptional patterns are subtle and/or obscured by other processes’ patterns. Consensus-independent component analysis (c-ICA) can dissect such transcriptomes into statistically independent transcriptional components (TCs), capturing both pronounced and subtle biological processes. Methods In this study we (1) integrated transcriptomes (n = 4228) from multiple early CRC studies, (2) performed c-ICA to define the TC landscape within this integrated data set, 3) determined the biological processes captured by these TCs, (4) performed Cox regression to identify DFS-associated TCs, (5) performed random survival forest (RSF) analyses with activity of DFS-associated TCs as classifiers to identify subgroups of patients, and 6) performed a sensitivity analysis to determine the robustness of our results Results We identify 191 TCs, 43 of which are associated with DFS, revealing transcriptional diversity among DFS-associated biological processes. A prominent example is the epithelial-mesenchymal transition (EMT), for which we identify an association with nine independent DFS-associated TCs, each with coordinated upregulation or downregulation of various sets of genes. Conclusions This finding indicates that early CRC may have nine distinct routes to achieve EMT, each requiring a specific peri-operative treatment strategy. Finally, we stratify patients into DFS patient subgroups with distinct transcriptional patterns associated with stage 2 and stage 3 CRC.
Abstract Background Bulk transcriptional profiles of early colorectal cancer (CRC) can fail to detect biological processes associated with disease-free survival (DFS) if the transcriptional patterns are subtle and/or obscured by other processes’ patterns. Consensus-independent component analysis (c-ICA) can dissect such transcriptomes into statistically independent transcriptional components (TCs), capturing both pronounced and subtle biological processes. Methods In this study we (1) integrated transcriptomes ( n  = 4228) from multiple early CRC studies, (2) performed c-ICA to define the TC landscape within this integrated data set, 3) determined the biological processes captured by these TCs, (4) performed Cox regression to identify DFS-associated TCs, (5) performed random survival forest (RSF) analyses with activity of DFS-associated TCs as classifiers to identify subgroups of patients, and 6) performed a sensitivity analysis to determine the robustness of our results Results We identify 191 TCs, 43 of which are associated with DFS, revealing transcriptional diversity among DFS-associated biological processes. A prominent example is the epithelial-mesenchymal transition (EMT), for which we identify an association with nine independent DFS-associated TCs, each with coordinated upregulation or downregulation of various sets of genes. Conclusions This finding indicates that early CRC may have nine distinct routes to achieve EMT, each requiring a specific peri-operative treatment strategy. Finally, we stratify patients into DFS patient subgroups with distinct transcriptional patterns associated with stage 2 and stage 3 CRC.
ArticleNumber 79
Author Dienstmann, Rodrigo
Fehrmann, Rudolf S. N.
de Haan, Jacco-Juri
Knapen, Daan G.
Hone Lopez, Sara
Bhattacharya, Arkajyoti
de Groot, Derk Jan A.
de Jong, Steven
de Vries, Elisabeth G. E.
Author_xml – sequence: 1
  givenname: Daan G.
  orcidid: 0000-0002-2523-137X
  surname: Knapen
  fullname: Knapen, Daan G.
  organization: Department of Medical Oncology, University Medical Center Groningen, University of Groningen
– sequence: 2
  givenname: Sara
  orcidid: 0000-0001-7615-3474
  surname: Hone Lopez
  fullname: Hone Lopez, Sara
  organization: Department of Medical Oncology, University Medical Center Groningen, University of Groningen
– sequence: 3
  givenname: Derk Jan A.
  surname: de Groot
  fullname: de Groot, Derk Jan A.
  organization: Department of Medical Oncology, University Medical Center Groningen, University of Groningen
– sequence: 4
  givenname: Jacco-Juri
  orcidid: 0000-0002-1629-4715
  surname: de Haan
  fullname: de Haan, Jacco-Juri
  organization: Department of Medical Oncology, University Medical Center Groningen, University of Groningen
– sequence: 5
  givenname: Elisabeth G. E.
  orcidid: 0000-0002-8949-7425
  surname: de Vries
  fullname: de Vries, Elisabeth G. E.
  organization: Department of Medical Oncology, University Medical Center Groningen, University of Groningen
– sequence: 6
  givenname: Rodrigo
  surname: Dienstmann
  fullname: Dienstmann, Rodrigo
  organization: Oncology Data Science (ODysSey) Group, Vall d’Hebron Institute of Oncology, Universitat Autónoma de Barcelona
– sequence: 7
  givenname: Steven
  orcidid: 0000-0001-5831-6997
  surname: de Jong
  fullname: de Jong, Steven
  organization: Department of Medical Oncology, University Medical Center Groningen, University of Groningen
– sequence: 8
  givenname: Arkajyoti
  orcidid: 0000-0003-1479-0739
  surname: Bhattacharya
  fullname: Bhattacharya, Arkajyoti
  organization: Department of Medical Oncology, University Medical Center Groningen, University of Groningen
– sequence: 9
  givenname: Rudolf S. N.
  orcidid: 0000-0002-7516-315X
  surname: Fehrmann
  fullname: Fehrmann, Rudolf S. N.
  email: r.s.n.fehrmann@umcg.nl
  organization: Department of Medical Oncology, University Medical Center Groningen, University of Groningen
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38702451$$D View this record in MEDLINE/PubMed
BookMark eNp9kc9vFSEQx4mpsbX2H_BgNvHiZZUFloWjafzxkiZeNPFG2GH2ycs-eAL7THvzP5d2azUevAAz85kvMN-n5CTEgIQ87-jrjnL1JguuetlSJlpKeyram0fkjA2ctlKKryd_nU_JRc47SikbpBaKPiGnXA21se_OyM9NcHjAuoTSlGRDhuQPxcdg5-ZgS8EUcpPwiDUefZzj1sNtKUXAnDE3NucI3hZ0zQ9fvjXOZ7QZ2ykhNnlJR3-svA8N2jRfN1AlEkKpObABMD0jjyc7Z7y438_Jl_fvPl9-bK8-fdhcvr1qgUtZWj3wqet7JXtwrkPNtaBajsJx3StEodnQT3KkEtA5ARStrT8eJwmT1VRSfk42q66LdmcOye9tujbRenOXiGlrbCoeZjTKDZPUFLUaQEgHljk6IpOgQCtgY9V6tWrVMXxfMBez9xlwnm3AuGTDqyNaMCpERV_-g-7ikup0V4oPfce6SrGVghRzTjg9PLCj5tZvs_ptqm3mzm9zU5te3Esv4x7dQ8tvdyvAVyDXUthi-nP3f2R_AR1Xut4
Cites_doi 10.3322/caac.21834
10.1038/nature11252
10.1038/s41467-020-14605-5
10.1038/s41588-022-01100-4
10.1016/j.cels.2015.12.004
10.1038/nm.3175
10.1016/j.celrep.2014.10.035
10.3390/cells8101118
10.1038/nm.3967
10.1038/ng.3173
10.1001/jama.2016.3332
10.1158/0008-5472.CAN-07-2938
10.1186/s13059-016-1070-5
10.1089/cmb.2004.11.1090
10.1007/978-1-4939-3578-9_5
10.5281/zenodo.10907204
10.18632/oncotarget.24132
10.1016/j.cell.2018.08.067
10.1038/nm.3174
10.1186/1755-8794-5-66
10.1038/ncomms15107
10.1074/jbc.RA117.000871
10.1002/ijc.28387
10.1038/s41392-022-01259-6
10.1016/j.annonc.2020.06.022
10.4149/neo_2020_190814N758
10.1158/0008-5472.CAN-07-0607
10.3390/molecules28145567
10.1093/bioinformatics/19.2.185
10.1038/s41467-021-21671-w
10.1200/JCO.20.02755
10.1038/s41375-019-0378-z
10.1371/journal.pmed.1001453
10.1186/1471-2407-11-529
10.1002/path.4212
10.2144/000112950
10.1038/nm.3802
10.1186/1471-2407-12-260
ContentType Journal Article
Copyright The Author(s) 2024
2024. The Author(s).
The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2024
– notice: 2024. The Author(s).
– notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
NPM
AAYXX
CITATION
3V.
7X7
7XB
88C
88E
8C1
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M0T
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOA
DOI 10.1038/s43856-024-00504-z
DatabaseName Springer Nature OA Free Journals
PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Healthcare Administration Database (Alumni)
Medical Database (Alumni Edition)
Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Healthcare Administration Database
Medical Database
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest Public Health
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Health Management
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Health Management (Alumni Edition)
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database

PubMed
MEDLINE - Academic

CrossRef
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2730-664X
EndPage 79
ExternalDocumentID oai_doaj_org_article_8d7f690e987c46dca2d0be26c8c98c2b
10_1038_s43856_024_00504_z
38702451
Genre Journal Article
GroupedDBID 0R~
53G
7X7
88E
8C1
8FI
8FJ
AAJSJ
ABUWG
ACLNF
ACSMW
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BENPR
C6C
CCPQU
EBLON
FYUFA
GROUPED_DOAJ
HMCUK
M0T
M1P
M~E
NAO
OK1
PGMZT
PIMPY
PSQYO
RPM
SNYQT
UKHRP
NPM
AAYXX
CITATION
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PQEST
PQQKQ
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c366t-973f155865cdd1e9394096b4d3958ee49275f6b06cedd4c0eaa002bf6cfa90603
IEDL.DBID C6C
ISSN 2730-664X
IngestDate Tue Oct 22 15:07:37 EDT 2024
Sat Oct 26 05:27:21 EDT 2024
Thu Oct 10 16:01:30 EDT 2024
Fri Aug 23 01:49:53 EDT 2024
Tue Oct 29 09:19:31 EDT 2024
Fri Oct 11 20:45:51 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2024. The Author(s).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c366t-973f155865cdd1e9394096b4d3958ee49275f6b06cedd4c0eaa002bf6cfa90603
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-1629-4715
0000-0002-7516-315X
0000-0002-2523-137X
0000-0001-5831-6997
0000-0003-1479-0739
0000-0002-8949-7425
0000-0001-7615-3474
OpenAccessLink https://doi.org/10.1038/s43856-024-00504-z
PMID 38702451
PQID 3050375121
PQPubID 5642959
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_8d7f690e987c46dca2d0be26c8c98c2b
proquest_miscellaneous_3050942044
proquest_journals_3050375121
crossref_primary_10_1038_s43856_024_00504_z
pubmed_primary_38702451
springer_journals_10_1038_s43856_024_00504_z
PublicationCentury 2000
PublicationDate 2024-05-03
PublicationDateYYYYMMDD 2024-05-03
PublicationDate_xml – month: 05
  year: 2024
  text: 2024-05-03
  day: 03
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Communications medicine
PublicationTitleAbbrev Commun Med
PublicationTitleAlternate Commun Med (Lond)
PublicationYear 2024
Publisher Nature Publishing Group UK
Springer Nature B.V
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Springer Nature B.V
– name: Nature Portfolio
References KongWVanderburgCRGunshinHRogersJTHuangXA review of independent component analysis application to microarray gene expression dataBiotechniques2008455015201:CAS:528:DC%2BD1cXhsVartb%2FN10.2144/000112950190073363005719
Perez-VillamilBColon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behaviorBMC Cancer2012121:CAS:528:DC%2BC3sXjsVShsr4%3D10.1186/1471-2407-12-260227125703571914
PangXTargeting integrin pathways: mechanisms and advances in therapySig. Transduct Target Ther.2023811:CAS:528:DC%2BB3sXkslChtQ%3D%3D10.1038/s41392-022-01259-6
Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 1–35 (2024).
MarisaLGene expression classification of colon cancer into molecular subtypes: characterisation, validation, and prognostic valuePloS Med.201310e10014531:CAS:528:DC%2BC3sXptlSisbo%3D10.1371/journal.pmed.1001453237003913660251
BudinskaEGene expression patterns unveil a new level of molecular heterogeneity in colorectal cancerJ. Pathol201323163761:CAS:528:DC%2BC3sXht1GhtLjF10.1002/path.4212238364653840702
RackKAEuropean recommendations and quality assurance for cytogenomic analysis of haematological neoplasmsLeukemia201933185118671:CAS:528:DC%2BC1MXhtVyrt77P10.1038/s41375-019-0378-z306969486756035
LinJSScreening for colorectal cancer: Updated evidence report and systematic review for the US preventive services task forceJAMA2016315257625941:CAS:528:DC%2BC28XhtFGqsbnO10.1001/jama.2016.333227305422
BitonAIndependent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypesCell Rep.20149123512451:CAS:528:DC%2BC2cXhvFGitL7N10.1016/j.celrep.2014.10.03525456126
BhattacharyaATranscriptional effects of copy number alterations in a large set of human cancersNat. Commun.2020111:CAS:528:DC%2BB3cXkvFWqt70%3D10.1038/s41467-020-14605-5320248387002723
SadanandamAA colorectal cancer classification system that associates cellular phenotype and responses to therapyNat. Med.2013196196251:CAS:528:DC%2BC3sXlsl2isLw%3D10.1038/nm.3175235840893774607
LiberzonAThe Molecular Signatures Database (MsigDB) hallmark gene set collectionCell Syst.201514174251:CAS:528:DC%2BC2sXhtFaltLc%3D10.1016/j.cels.2015.12.004267710214707969
IsellaCSelective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancerNat. Commun.201781:CAS:528:DC%2BC2sXovFCls7s%3D10.1038/ncomms15107285610635499209
OnderTTLoss of E-cadherin promotes metastasis via multiple downstream transcriptional pathwaysCancer Res.200868364536541:CAS:528:DC%2BD1cXlvVOitLw%3D10.1158/0008-5472.CAN-07-293818483246
SananesAA potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineeringJ. Biol. Chem.201829312663126801:CAS:528:DC%2BC1cXhsFeiu73K10.1074/jbc.RA117.000871299343096102146
GuinneyJThe consensus molecular subtypes of colorectal cancerNat. Med.201521135013561:CAS:528:DC%2BC2MXhs1Chu77M10.1038/nm.3967264577594636487
Arkajyotibhattacharya. arkajyotibhattacharya/TranscriptionalLandscapeColorectalCancer: Transcriptional landscape of colorectal cancer (TranscriptionalLandscapeColorectalCancer). Zenodo. https://doi.org/10.5281/zenodo.10907204 (2024).
CloughEBarrettTThe gene expression Omnibus DatabaseMethods Mol. Biol.201614189311010.1007/978-1-4939-3578-9_5270080114944384
AnastassiouDHuman cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivoBMC Cancer2011111:CAS:528:DC%2BC38XisFyltr0%3D10.1186/1471-2407-11-529222089483268117
BolstadBMIrizarryRAAstrandMSpeedTPAComparison of normalization methods for high density oligonucleotide array data based on variance and biasBioinformatics2003191851931:CAS:528:DC%2BD3sXitlCnsL4%3D10.1093/bioinformatics/19.2.18512538238
WeiHDongCShenZKallikrein-related peptidase (KLK10) cessation blunts colorectal cancer growth and glucose metabolism by regulating the PI3K/Akt/mTOR pathwayNeoplasma2020678898971:CAS:528:DC%2BB3MXit12ksbrK10.4149/neo_2020_190814N75832386481
JoanitoISingle-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancerNat. Gene2022549639751:CAS:528:DC%2BB38XhslSls7%2FF10.1038/s41588-022-01100-4
BechtEEstimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expressionGenome Biol.20161710.1186/s13059-016-1070-5277650665073889
Urzúa-TraslaviñaCGImproving gene function predictions using independent transcriptional componentsNat. Commun.20211210.1038/s41467-021-21671-w336746107935959
KinchenJStructual remodeling of the human colonic mesenchyme in inflammatory bowel diseaseCell.20181753723861:CAS:528:DC%2BC1cXhvVahsLfL10.1016/j.cell.2018.08.067302700426176871
ChiappettaPRoubaudMCTorrésaniBBlind source separation and the analysis of microarray dataJ. Comput. Biol.200411109011091:CAS:528:DC%2BD2MXhtFersbo%3D10.1089/cmb.2004.11.109015662200
MatanoMModeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoidsNat. Med.2015212562621:CAS:528:DC%2BC2MXjtFemsLg%3D10.1038/nm.380225706875
ArgilesGLocalised colon cancer: ESMO clinical practice guidelines for diagnosis treatment and follow upAnn. Oncol.202031129113051:STN:280:DC%2BB38jmt1Wnug%3D%3D10.1016/j.annonc.2020.06.02232702383
KluckyBKallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasionCancer Res.200767819882061:CAS:528:DC%2BD2sXpvFKjtbc%3D10.1158/0008-5472.CAN-07-060717804733
ShahMAPhase III study to evaluate efficacy and safety of andecaliximab with mFOLFOX6 as first-line treatment in patients with advanced gastric or GEJ adenocarcinoma (GAMMA-1)J. Clin. Oncol.20213999010001:CAS:528:DC%2BB38XhslKltbY%3D10.1200/JCO.20.02755335773588078292
RoepmanPColorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transitionInt. J. Cancer20141345525621:CAS:528:DC%2BC3sXhsVeqsrzF10.1002/ijc.2838723852808
SchlickerASubtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell linesBMC Med. Genomics201251:CAS:528:DC%2BC3sXhsFyjtbk%3D10.1186/1755-8794-5-66232729493543849
FehrmannRSNGene expression analysis identifies global gene dosage sensitivity in cancerNat. Genet.2015471151251:CAS:528:DC%2BC2MXmtV2rsw%3D%3D10.1038/ng.317325581432
The Cancer Genome Atlas Network.Comprehensive molecular characterization of human colon and rectal cancerNature201348733033710.1038/nature11252
De SousaEPoor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesionsNat. Med.20131961461810.1038/nm.3174
LohCYThe E-cadherin and N-cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challengesCells2019811181:CAS:528:DC%2BB3cXnvVymsL0%3D10.3390/cells8101118315471936830116
DuJPKallikrein-related peptidase 7 is a potential target for the treatment of pancreatic cancerOncotarget20189128941290610.18632/oncotarget.24132295601185849182
RaoYLiuHYanXWangJIn silico analysis identifies differently expressed lncRNAs as novel biomarkers for the prognosis of thyroid cancerComput. Math. Methods Me.d202020203651051
AlmutairiSKalloushHMManoonNABardaweelSKMatrix metalloproteinases inhibitors in cancer treatment: An updated review (2013–2023)Molecules20232855671:CAS:528:DC%2BB3sXhs1aksL3M10.3390/molecules281455673751344010384300
A Sananes (504_CR29) 2018; 293
The Cancer Genome Atlas Network. (504_CR36) 2013; 487
P Chiappetta (504_CR14) 2004; 11
E Clough (504_CR16) 2016; 1418
504_CR39
C Isella (504_CR23) 2017; 8
A Sadanandam (504_CR9) 2013; 19
H Wei (504_CR27) 2020; 67
504_CR1
A Bhattacharya (504_CR19) 2020; 11
A Schlicker (504_CR10) 2012; 5
S Almutairi (504_CR34) 2023; 28
JS Lin (504_CR2) 2016; 315
E Becht (504_CR18) 2016; 17
D Anastassiou (504_CR31) 2011; 11
B Perez-Villamil (504_CR7) 2012; 12
A Biton (504_CR15) 2014; 9
CG Urzúa-Traslaviña (504_CR21) 2021; 12
A Liberzon (504_CR20) 2015; 1
BM Bolstad (504_CR17) 2003; 19
KA Rack (504_CR38) 2019; 33
B Klucky (504_CR28) 2007; 67
MA Shah (504_CR35) 2021; 39
P Roepman (504_CR8) 2014; 134
W Kong (504_CR13) 2008; 45
G Argiles (504_CR3) 2020; 31
JP Du (504_CR30) 2018; 9
I Joanito (504_CR24) 2022; 54
J Guinney (504_CR11) 2015; 21
Y Rao (504_CR32) 2020; 2020
X Pang (504_CR33) 2023; 8
J Kinchen (504_CR22) 2018; 175
RSN Fehrmann (504_CR12) 2015; 47
TT Onder (504_CR25) 2008; 68
E Budinska (504_CR4) 2013; 231
L Marisa (504_CR6) 2013; 10
M Matano (504_CR37) 2015; 21
E De Sousa (504_CR5) 2013; 19
CY Loh (504_CR26) 2019; 8
References_xml – ident: 504_CR1
  doi: 10.3322/caac.21834
– volume: 487
  start-page: 330
  year: 2013
  ident: 504_CR36
  publication-title: Nature
  doi: 10.1038/nature11252
  contributor:
    fullname: The Cancer Genome Atlas Network.
– volume: 11
  year: 2020
  ident: 504_CR19
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-14605-5
  contributor:
    fullname: A Bhattacharya
– volume: 54
  start-page: 963
  year: 2022
  ident: 504_CR24
  publication-title: Nat. Gene
  doi: 10.1038/s41588-022-01100-4
  contributor:
    fullname: I Joanito
– volume: 1
  start-page: 417
  year: 2015
  ident: 504_CR20
  publication-title: Cell Syst.
  doi: 10.1016/j.cels.2015.12.004
  contributor:
    fullname: A Liberzon
– volume: 19
  start-page: 619
  year: 2013
  ident: 504_CR9
  publication-title: Nat. Med.
  doi: 10.1038/nm.3175
  contributor:
    fullname: A Sadanandam
– volume: 9
  start-page: 1235
  year: 2014
  ident: 504_CR15
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2014.10.035
  contributor:
    fullname: A Biton
– volume: 8
  start-page: 1118
  year: 2019
  ident: 504_CR26
  publication-title: Cells
  doi: 10.3390/cells8101118
  contributor:
    fullname: CY Loh
– volume: 21
  start-page: 1350
  year: 2015
  ident: 504_CR11
  publication-title: Nat. Med.
  doi: 10.1038/nm.3967
  contributor:
    fullname: J Guinney
– volume: 47
  start-page: 115
  year: 2015
  ident: 504_CR12
  publication-title: Nat. Genet.
  doi: 10.1038/ng.3173
  contributor:
    fullname: RSN Fehrmann
– volume: 315
  start-page: 2576
  year: 2016
  ident: 504_CR2
  publication-title: JAMA
  doi: 10.1001/jama.2016.3332
  contributor:
    fullname: JS Lin
– volume: 68
  start-page: 3645
  year: 2008
  ident: 504_CR25
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-07-2938
  contributor:
    fullname: TT Onder
– volume: 17
  year: 2016
  ident: 504_CR18
  publication-title: Genome Biol.
  doi: 10.1186/s13059-016-1070-5
  contributor:
    fullname: E Becht
– volume: 11
  start-page: 1090
  year: 2004
  ident: 504_CR14
  publication-title: J. Comput. Biol.
  doi: 10.1089/cmb.2004.11.1090
  contributor:
    fullname: P Chiappetta
– volume: 1418
  start-page: 93
  year: 2016
  ident: 504_CR16
  publication-title: Methods Mol. Biol.
  doi: 10.1007/978-1-4939-3578-9_5
  contributor:
    fullname: E Clough
– ident: 504_CR39
  doi: 10.5281/zenodo.10907204
– volume: 9
  start-page: 12894
  year: 2018
  ident: 504_CR30
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.24132
  contributor:
    fullname: JP Du
– volume: 175
  start-page: 372
  year: 2018
  ident: 504_CR22
  publication-title: Cell.
  doi: 10.1016/j.cell.2018.08.067
  contributor:
    fullname: J Kinchen
– volume: 19
  start-page: 614
  year: 2013
  ident: 504_CR5
  publication-title: Nat. Med.
  doi: 10.1038/nm.3174
  contributor:
    fullname: E De Sousa
– volume: 5
  year: 2012
  ident: 504_CR10
  publication-title: BMC Med. Genomics
  doi: 10.1186/1755-8794-5-66
  contributor:
    fullname: A Schlicker
– volume: 8
  year: 2017
  ident: 504_CR23
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms15107
  contributor:
    fullname: C Isella
– volume: 293
  start-page: 12663
  year: 2018
  ident: 504_CR29
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.RA117.000871
  contributor:
    fullname: A Sananes
– volume: 134
  start-page: 552
  year: 2014
  ident: 504_CR8
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.28387
  contributor:
    fullname: P Roepman
– volume: 8
  start-page: 1
  year: 2023
  ident: 504_CR33
  publication-title: Sig. Transduct Target Ther.
  doi: 10.1038/s41392-022-01259-6
  contributor:
    fullname: X Pang
– volume: 31
  start-page: 1291
  year: 2020
  ident: 504_CR3
  publication-title: Ann. Oncol.
  doi: 10.1016/j.annonc.2020.06.022
  contributor:
    fullname: G Argiles
– volume: 67
  start-page: 889
  year: 2020
  ident: 504_CR27
  publication-title: Neoplasma
  doi: 10.4149/neo_2020_190814N758
  contributor:
    fullname: H Wei
– volume: 67
  start-page: 8198
  year: 2007
  ident: 504_CR28
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-07-0607
  contributor:
    fullname: B Klucky
– volume: 28
  start-page: 5567
  year: 2023
  ident: 504_CR34
  publication-title: Molecules
  doi: 10.3390/molecules28145567
  contributor:
    fullname: S Almutairi
– volume: 19
  start-page: 185
  year: 2003
  ident: 504_CR17
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/19.2.185
  contributor:
    fullname: BM Bolstad
– volume: 12
  year: 2021
  ident: 504_CR21
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-21671-w
  contributor:
    fullname: CG Urzúa-Traslaviña
– volume: 2020
  start-page: 3651051
  year: 2020
  ident: 504_CR32
  publication-title: Comput. Math. Methods Me.d
  contributor:
    fullname: Y Rao
– volume: 39
  start-page: 990
  year: 2021
  ident: 504_CR35
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.20.02755
  contributor:
    fullname: MA Shah
– volume: 33
  start-page: 1851
  year: 2019
  ident: 504_CR38
  publication-title: Leukemia
  doi: 10.1038/s41375-019-0378-z
  contributor:
    fullname: KA Rack
– volume: 10
  start-page: e1001453
  year: 2013
  ident: 504_CR6
  publication-title: PloS Med.
  doi: 10.1371/journal.pmed.1001453
  contributor:
    fullname: L Marisa
– volume: 11
  year: 2011
  ident: 504_CR31
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-11-529
  contributor:
    fullname: D Anastassiou
– volume: 231
  start-page: 63
  year: 2013
  ident: 504_CR4
  publication-title: J. Pathol
  doi: 10.1002/path.4212
  contributor:
    fullname: E Budinska
– volume: 45
  start-page: 501
  year: 2008
  ident: 504_CR13
  publication-title: Biotechniques
  doi: 10.2144/000112950
  contributor:
    fullname: W Kong
– volume: 21
  start-page: 256
  year: 2015
  ident: 504_CR37
  publication-title: Nat. Med.
  doi: 10.1038/nm.3802
  contributor:
    fullname: M Matano
– volume: 12
  year: 2012
  ident: 504_CR7
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-12-260
  contributor:
    fullname: B Perez-Villamil
SSID ssj0002769480
Score 2.3084135
Snippet Background Bulk transcriptional profiles of early colorectal cancer (CRC) can fail to detect biological processes associated with disease-free survival (DFS)...
Bulk transcriptional profiles of early colorectal cancer (CRC) can fail to detect biological processes associated with disease-free survival (DFS) if the...
Abstract Background Bulk transcriptional profiles of early colorectal cancer (CRC) can fail to detect biological processes associated with disease-free...
BackgroundBulk transcriptional profiles of early colorectal cancer (CRC) can fail to detect biological processes associated with disease-free survival (DFS) if...
BACKGROUNDBulk transcriptional profiles of early colorectal cancer (CRC) can fail to detect biological processes associated with disease-free survival (DFS) if...
Abstract Background Bulk transcriptional profiles of early colorectal cancer (CRC) can fail to detect biological processes associated with disease-free...
SourceID doaj
proquest
crossref
pubmed
springer
SourceType Open Website
Aggregation Database
Index Database
Publisher
StartPage 79
SubjectTerms 38
631/67/1504/1885
631/67/69
Cancer therapies
Colorectal cancer
Datasets
Gene expression
Integrated approach
Large intestine
Medicine
Medicine & Public Health
Patients
Principal components analysis
Regression analysis
Sarcoma
Sensitivity analysis
Survival analysis
Transcription factors
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV29b9UwELdQJxYEgkKgICOxgVW_-CP22CKqglQmKnWzEvsswZA-veQt3fjPubPzHkWAunSM41j2ffkuZ_-OsXeAJk91HhUJMFbVGHyJvk1ZdKhLNqsWXCnTefHVnl_qL1fm6lapLzoTVuGBK-GOXeoyRnCAsXHUNkUcSQ7Q2uiid7EdivWV_lYw9aOk06zXTi63ZKRyx5NWztB5Wy0I80SLmz92ogLY_y8v868Madl4zh6zR4vHyE_qTJ-wBzA-ZT8_78vXznym_Wan_dh1XTAzx4kTPBM-V6Al4gZf13sBMPF-4QskTv9i-ZKpEXkDwKctWhCUQf595EAQyJzArck4YlskQdk8Y5dnn759PBdLNQURlbWz8J3K6Dw4a2JKK_BUEt3bQSfljQPQvu1MtoO0EVLSUULfIx2HbGPuvbRSHbKD8XqEF4ynbFZoGXwyw4Dxme09OVKm67vskF-qYe93lA3rCpoRSrJbuVD5EJAPofAh3DTslIi_70mA16UBxSAsYhDuEoOGHe1YFxYtnIIisJsOXZpVw97uX6P-UFKkH-F6W_t43UqtG_a8snw_E4XGrNUGv_6wk4Hfg_9_QS_vY0Gv2MO2CKsRUh2xg3mzhdfo_8zDmyLqvwDgqQOV
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Public Health Database
  dbid: 8C1
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Jb9UwELagXLggUFkCBRmJG1hN4v2EaEXVIsGJSr1ZiRfEJe_1Je_SW_85M46TCrEc4ziW49k99jeEvIug8ri2IEgRYlUBwRfr2pCYBllSibfR5DKdX7-p80vx5UpelQ23sRyrXHRiVtRh43GP_JgjcIkG89R83F4zrBqF2dVSQuM-edCAncPgy5w26x5Lq5UVpi53ZWpujkfBjcRTt4Ih8olgN7_Zowzb_zdf8488aTY_Z4_Jo-I30k8zoZ-Qe3E4JLcXaxHbiU5odRYdAF23GTlzGCmCNMHzDLeENKHb-XZAHGlXqBMDxR1ZWvI1LO1ipOMe9AhwIv050IhAyBQhrlFFQptHdtk9JZdnn7-fnrNSU4F5rtTErOYJXAijpA-hiRYLo1vVi8CtNDEK22qZVF8rH0MQvo5dB-vYJ-VTZ2tV82fkYNgM8QWhIckG9IMNsu8hSlOdRXdK6k4nY4LmFXm_rKzbztAZLqe8uXEzHRzQwWU6uJuKnODirz0R9jo3bHY_XJEiB8MmCOejNdoLFTywVd3HVnnjrfFtX5GjhXSuyOLo7jinIm_X1yBFmBrphrjZz32saGshKvJ8Jvk6Ew4qrRUSvv6w8MDd4P_-oZf_n8sr8rDNbChZzY_IwbTbx9fg30z9m8zEvwBAWPmw
  priority: 102
  providerName: ProQuest
Title Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancer
URI https://link.springer.com/article/10.1038/s43856-024-00504-z
https://www.ncbi.nlm.nih.gov/pubmed/38702451
https://www.proquest.com/docview/3050375121
https://search.proquest.com/docview/3050942044
https://doaj.org/article/8d7f690e987c46dca2d0be26c8c98c2b
Volume 4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEB6aBEovpe-4TY0KvbWmXut9bJaEtJBQSgN7E7Y0gl6cZdd7ya3_vCPZ6xKaHnoxWJaErW9mNNJY3wC8RzJ5XFtSJKS1qqDFV9U2IVaadElF3qDJaTovr9TFtfi6kquJJiedhbkTv-fm01ZwI9NvsqJKVCWiuj2AozQHpzQNS7Wc91Maraww9XQu5v6md-aeTNF_n1_5V0w0TzXnT-Dx5COyzyOoT-EB9s_g4eUUBX8Ov77MuWsHNqTJZq_61GqdCTP7LUvcTHQ_siwlKNh6PBSAW9ZOoGBgaSOWTWGaKm4Q2XZH5oMEkP3sGSb-Y5aYrZNlpDKfpGTzAq7Pz34sL6oplULluVJDZTWP5DkYJX0IC7QpH7pVnQjcSoMobKNlVF2tPIYgfI1tS0PaReVja2tV85dw2N_0eAwsRLkgs2CD7DpanKnWJi9K6lZHY4LmBXzYD7Jbj4wZLke6uXEjJI4gcRkSd1vAacJhrpnYrnMBCYGblMdRt5FW8WiN9kIFT9JUd9gob7w1vukKONmj6CYV3DqemG40-TOLAt7Nj0l5UkSk7fFmN9axoqmFKODViP78JpwsWSMktf64F4c_nf_7g17_X_U38KjJEiqrmp_A4bDZ4Vtyc4auhAO90nQ1y0UJR6dnV9--l1nmy7xxUOadqd9Divvz
link.rule.ids 315,783,787,867,2109,12070,12237,21402,27938,27939,31733,31734,33280,33281,33758,33759,41134,42203,43324,43593,43819,51590,74081,74350,74638
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Jb9QwFLagHOCCQGyBAkbiBlYz8X5CgKim0PbUSnOzEi-ol8wwyVx645_znuNMhViOcRzL8Vv8Fvt7hLyNoPK4tiBIEXxVAc4Xa5uQmAZZUok30eQynWfnankpvq7kqgTchnKsctaJWVGHtccY-RFH4BIN29Piw-YHw6pRmF0tJTRukzuIw4XY-Xql9zGWRisrTF3uytTcHA2CG4mnbgVD5BPBrn_bjzJs_99szT_ypHn7OX5A7he7kX6cCP2Q3Ir9I_LzZF_EdqQj7jqzDoCum4yc2Q8UQZrgeYJbQprQzXQ7IA60LdSJgWJElpZ8DUvbGOmwAz0CnEivehoRCJkixDWqSGjzyC7bx-Ty-MvF5yUrNRWY50qNzGqewIQwSvoQFtFiYXSrOhG4lSZGYRstk-pq5WMIwtexbWEdu6R8am2tav6EHPTrPj4jNCS5AP1gg-w68NJUa9GckrrVyZigeUXezSvrNhN0hsspb27cRAcHdHCZDu66Ip9w8fc9EfY6N6y3312RIgfDJnDnozXaCxU8sFXdxUZ5463xTVeRw5l0rsji4G44pyJv9q9BijA10vZxvZv6WNHUQlTk6UTy_Uw4qLRGSPj6_cwDN4P_-4ee_38ur8nd5cXZqTs9Of_2gtxrMktKVvNDcjBud_El2Dpj9yoz9C9k2vzP
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZgKyEuCMQrUMBI3MDabPw-IQpdtTxWFaJSb1biR8Ulu2yyl97458wkzlaIxzGOYzmeb8Zjj_0NIa8imDyuLShShLWqgMUXq6uQmAZdUolX0QxpOr-s1Mm5-HghL_L5py4fq5xs4mCow9rjHvmcI3GJhulpMU_5WMTZh-XbzQ-GGaQw0prTadwkB1oAqmbk4Oh4dfZ1v-NSaWWFKfPNmZKbeSe4kXgGVzDkQRHs6rfZaSDx_5vn-UfUdJiMlnfJnexF0nej2O-RG7G9T36e7lPa9rTHOWiyCFB1M_Both1FyiZ4HsmXUEJ0M94ViB2ts6xioLg_S3P0hqVtjLTbgVUBXNLvLY1Ii0yR8BoNJpR5BM_2ATlfHn97f8JyhgXmuVI9s5oncCiMkj6ERbSYJt2qRgRupYlR2ErLpJpS-RiC8GWsaxjHJimfaluqkj8ks3bdxseEhiQXYC1skE0DazZVW3SupK51MiZoXpDX08i6zUik4YYAODdulIMDObhBDu6qIEc4-PuaSII9FKy3ly7rlINmEyzuozXaCxU8gKxsYqW88db4qinI4SQ6lzWzc9c4KsjL_WvQKQyU1G1c78Y6VlSlEAV5NIp83xMOBq4SEr5-M2HguvF__9CT__flBbkFaHafT1efnpLb1YBIyUp-SGb9dhefgePTN88zon8Bm-0CgQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Independent+transcriptional+patterns+reveal+biological+processes+associated+with+disease-free+survival+in+early+colorectal+cancer&rft.jtitle=Communications+medicine&rft.au=Knapen%2C+Daan+G.&rft.au=Hone+Lopez%2C+Sara&rft.au=de+Groot%2C+Derk+Jan+A.&rft.au=de+Haan%2C+Jacco-Juri&rft.date=2024-05-03&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2730-664X&rft.volume=4&rft.issue=1&rft_id=info:doi/10.1038%2Fs43856-024-00504-z&rft.externalDocID=10_1038_s43856_024_00504_z
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2730-664X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2730-664X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2730-664X&client=summon